Alpha Teknova, Inc. cash flow statement
In fiscal 2025, Alpha Teknova, Inc.'s operations generated −$8.6m of cash; it spent $1.1m on capital projects, leaving free cash flow of −$9.8m.
Cash flow statement
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 3 | −9 | −27 | −19 | −12 | −9 | −6 |
| Depreciation and amortisation | 2 | 3 | 3 | 6 | 7 | 6 | 6 |
| Stock-based pay | 0 | 2 | 4 | 4 | 4 | 3 | 3 |
| Capital spending | 5 | 20 | 28 | 8 | 1 | 1 | 1 |
| Free cash flow | −3 | −29 | −56 | −27 | −14 | −10 | −7 |
| Free cash flow after stock pay | −3 | −30 | −59 | −31 | −17 | −13 | −10 |
| Shares issued | — | — | 0 | 23 | 15 | 0 | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −2 | −1 | −4 | −2 | −2 | −0 | −3 | −0 |
| Depreciation and amortisation | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 1 |
| Stock-based pay | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Capital spending | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −2 | −2 | −4 | −2 | −2 | −1 | −4 | −1 |
| Free cash flow after stock pay | −3 | −2 | −5 | −3 | −3 | −2 | −4 | −1 |
| Shares issued | 15 | 0 | — | — | — | 0 | — | — |
Compare with peers
- Omniab, Inc. cash flow
- Rapid Micro Biosystems, Inc. cash flow
- Champions Oncology, Inc. cash flow
- Precipio, Inc. cash flow
- 908 Devices Inc. cash flow
Head to head: OABI vs TKNORPID vs TKNOCSBR vs TKNO
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies